These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 11330619

  • 1. Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999).
    McManus PM, Craig LE.
    J Am Vet Med Assoc; 2001 Apr 15; 218(8):1308-13. PubMed ID: 11330619
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A, Mackin A.
    Compend Contin Educ Vet; 2007 Apr 15; 29(4):217-25. PubMed ID: 17726851
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography.
    Fenty RK, Delaforcade AM, Shaw SE, O'Toole TE.
    J Am Vet Med Assoc; 2011 Feb 15; 238(4):463-7. PubMed ID: 21320015
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The utility of diagnostic tests for immune-mediated hemolytic anemia.
    Members of the Veterinary and Comparative Clinical Immunology Society Diagnostic Task Force, MacNeill AL, Dandrieux J, Lubas G, Seelig D, Szladovits B.
    Vet Clin Pathol; 2019 Oct 15; 48 Suppl 1():7-16. PubMed ID: 31502273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical, biochemical, and hematological characteristics, disease prevalence, and prognosis of dogs presenting with neutrophil cytoplasmic toxicity.
    Aroch I, Klement E, Segev G.
    J Vet Intern Med; 2005 Oct 15; 19(1):64-73. PubMed ID: 15715050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of prognostic indicators for canine primary immune-mediated haemolytic anaemia and application of a scoring system for the determination of prognosis.
    Ke SS, Anderson GA, Connolly SL.
    Aust Vet J; 2015 Apr 15; 93(4):93-8. PubMed ID: 25817973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK, Center SA, Randolph JF, Warner KL, Barr SC, Erb HN.
    J Am Vet Med Assoc; 2005 Jun 01; 226(11):1869-80. PubMed ID: 15934255
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.